Legal Representation
Attorney
Ilene B. Tannen
USPTO Deadlines
Next Deadline
154 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
January 04, 2026
Extension Available
Until July 04, 2024
Application History
41 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 23, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jun 23, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jun 23, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
May 13, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
May 12, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
May 12, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
May 12, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Nov 18, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Nov 18, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Nov 18, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Nov 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
May 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
May 23, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
May 23, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
May 23, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Nov 21, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Nov 17, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Nov 17, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Nov 17, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jul 4, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
May 9, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 9, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 19, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Mar 31, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Mar 18, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Mar 18, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
Mar 17, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Mar 17, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Mar 17, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Mar 1, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Mar 1, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 1, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Feb 2, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 1, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 1, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 8, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 8, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Aug 8, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Aug 4, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 19, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Nov 18, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Class 044
Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases
Additional Information
Design Mark
The mark consists of the combined words "ngmBIO" with "ngm" in lowercase stylized letters and "BIO" in uppercase stylized letters.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"